HIK — Hikma Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Market Cap
£3.94bn
Enterprise Value
£4.93bn
Revenue
$3.16bn

REG - Hikma Pharmaceutical - Block listing Interim Review
01/10/2025 12:00Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
23/09/2025 14:00Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
17/09/2025 09:30Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
22/08/2025 12:15Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
13/08/2025 14:00Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
08/08/2025 13:00Announcement
REG - Hikma Pharmaceutical - Half-year Report
07/08/2025 07:00Announcement
REG - Stock Exch Notice - Admission to ISM - 09/07/2025
09/07/2025 09:00Announcement
REG - Hikma Pharmaceutical - Notice of Results
09/07/2025 09:00Announcement
REG - Hikma Pharmaceutical - Publication of Offering Circular
07/07/2025 09:30Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
09/06/2025 15:45Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
05/06/2025 14:15Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
03/06/2025 13:15Announcement
REG - Hikma Pharmaceutical - Fitch upgrades Hikma to ‘BBB’
29/05/2025 07:00Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
20/05/2025 15:00Announcement
REG - Hikma Pharmaceutical - Medium-term Group guidance ahead of US site visit
15/05/2025 12:00Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
08/05/2025 16:45Announcement
REG - Hikma Pharmaceutical - S&P upgrades Hikma to ‘BBB’
08/05/2025 11:00Announcement
REG - Hikma Pharmaceutical - Settlement agreement for Xyrem® US lawsuits
08/05/2025 08:30Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
30/04/2025 13:30Announcement